Literature DB >> 31142498

Host-Pathogen Interactions in Gram-Positive Bacterial Pneumonia.

Jennifer A Grousd1, Helen E Rich1, John F Alcorn2.   

Abstract

Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide. Despite broad literature including basic and translational scientific studies, many gaps in our understanding of host-pathogen interactions remain. In this review, pathogen virulence factors that drive lung infection and injury are discussed in relation to their associated host immune pathways. CAP epidemiology is considered, with a focus on Staphylococcus aureus and Streptococcus pneumoniae as primary pathogens. Bacterial factors involved in nasal colonization and subsequent virulence are illuminated. A particular emphasis is placed on bacterial pore-forming toxins, host cell death, and inflammasome activation. Identified host-pathogen interactions are then examined by linking pathogen factors to aberrant host response pathways in the context of acute lung injury in both primary and secondary infection. While much is known regarding bacterial virulence and host immune responses, CAP management is still limited to mostly supportive care. It is likely that improvements in therapy will be derived from combinatorial targeting of both pathogen virulence factors and host immunomodulation.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  inflammation; influenza; lung; staphylococcus; streptococcus; superinfection

Mesh:

Year:  2019        PMID: 31142498      PMCID: PMC6589866          DOI: 10.1128/CMR.00107-18

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  171 in total

Review 1.  The pneumococcus: epidemiology, microbiology, and pathogenesis.

Authors:  Birgitta Henriques-Normark; Elaine I Tuomanen
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

Review 2.  The amazing innate immune response to influenza A virus infection.

Authors:  Shweta Tripathi; Mitchell R White; Kevan L Hartshorn
Journal:  Innate Immun       Date:  2013-11-11       Impact factor: 2.680

3.  Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults.

Authors:  Seema Jain; Wesley H Self; Richard G Wunderink; Sherene Fakhran; Robert Balk; Anna M Bramley; Carrie Reed; Carlos G Grijalva; Evan J Anderson; D Mark Courtney; James D Chappell; Chao Qi; Eric M Hart; Frank Carroll; Christopher Trabue; Helen K Donnelly; Derek J Williams; Yuwei Zhu; Sandra R Arnold; Krow Ampofo; Grant W Waterer; Min Levine; Stephen Lindstrom; Jonas M Winchell; Jacqueline M Katz; Dean Erdman; Eileen Schneider; Lauri A Hicks; Jonathan A McCullers; Andrew T Pavia; Kathryn M Edwards; Lyn Finelli
Journal:  N Engl J Med       Date:  2015-07-14       Impact factor: 91.245

4.  Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children.

Authors:  Clarence B Creech; Douglas S Kernodle; Andrew Alsentzer; Cynthia Wilson; Kathryn M Edwards
Journal:  Pediatr Infect Dis J       Date:  2005-07       Impact factor: 2.129

5.  Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia.

Authors:  Brook E Ragle; Juliane Bubeck Wardenburg
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.441

6.  Influenza-associated pediatric deaths in the United States, 2004-2012.

Authors:  Karen K Wong; Seema Jain; Lenee Blanton; Rosaline Dhara; Lynnette Brammer; Alicia M Fry; Lyn Finelli
Journal:  Pediatrics       Date:  2013-10-28       Impact factor: 7.124

7.  The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors.

Authors:  András N Spaan; Manouk Vrieling; Pierre Wallet; Cédric Badiou; Tamara Reyes-Robles; Elizabeth A Ohneck; Yvonne Benito; Carla J C de Haas; Christopher J Day; Michael P Jennings; Gérard Lina; François Vandenesch; Kok P M van Kessel; Victor J Torres; Jos A G van Strijp; Thomas Henry
Journal:  Nat Commun       Date:  2014-11-11       Impact factor: 14.919

8.  Counter inhibition between leukotoxins attenuates Staphylococcus aureus virulence.

Authors:  Pauline Yoong; Victor J Torres
Journal:  Nat Commun       Date:  2015-09-02       Impact factor: 14.919

9.  Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study.

Authors:  Lone Simonsen; Peter Spreeuwenberg; Roger Lustig; Robert J Taylor; Douglas M Fleming; Madelon Kroneman; Maria D Van Kerkhove; Anthony W Mounts; W John Paget
Journal:  PLoS Med       Date:  2013-11-26       Impact factor: 11.069

Review 10.  Interaction of Bacterial Exotoxins with Neutrophil Extracellular Traps: Impact for the Infected Host.

Authors:  Maren von Köckritz-Blickwede; Stefanie Blodkamp; Victor Nizet
Journal:  Front Microbiol       Date:  2016-03-30       Impact factor: 5.640

View more
  11 in total

1.  Hemoglobin Induces Early and Robust Biofilm Development in Streptococcus pneumoniae by a Pathway That Involves comC but Not the Cognate comDE Two-Component System.

Authors:  Fahmina Akhter; Edroyal Womack; Jorge E Vidal; Yoann Le Breton; Kevin S McIver; Shrikant Pawar; Zehava Eichenbaum
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

2.  The pro-inflammatory effect of Staphylokinase contributes to community-associated Staphylococcus aureus pneumonia.

Authors:  Yanan Wang; Na Zhao; Ying Jian; Yao Liu; Lin Zhao; Lei He; Qian Liu; Min Li
Journal:  Commun Biol       Date:  2022-06-23

3.  The rapid and visual detection of methicillin-susceptible and methicillin-resistant Staphylococcus aureus using multiplex loop-mediated isothermal amplification linked to a nanoparticle-based lateral flow biosensor.

Authors:  Xu Chen; Kai Ma; Xu Yi; Lijuan Xiong; Yu Wang; Shijun Li
Journal:  Antimicrob Resist Infect Control       Date:  2020-07-17       Impact factor: 4.887

4.  Drivers of methicillin-resistant Staphylococcus aureus (MRSA) lineage replacement in China.

Authors:  Hongbin Chen; Yuyao Yin; Lucy van Dorp; Liam P Shaw; Hua Gao; Mislav Acman; Jizhen Yuan; Fengning Chen; Shijun Sun; Xiaojuan Wang; Shuguang Li; Yawei Zhang; Rhys A Farrer; Hui Wang; Francois Balloux
Journal:  Genome Med       Date:  2021-10-28       Impact factor: 11.117

5.  Therapeutic potential of kaempferol on Streptococcus pneumoniae infection.

Authors:  Lei Xu; Juan Fang; Deyuan Ou; Jingwen Xu; Xuming Deng; Gefu Chi; Haihua Feng; Jianfeng Wang
Journal:  Microbes Infect       Date:  2022-10-07       Impact factor: 9.570

Review 6.  Dual Role of Hydrogen Peroxide as an Oxidant in Pneumococcal Pneumonia.

Authors:  Mobarak Abu Mraheil; Haroldo A Toque; Luigi La Pietra; Juerg Hamacher; Tenzing Phanthok; Alexander Verin; Joyce Gonzales; Yunchao Su; David Fulton; Douglas C Eaton; Trinad Chakraborty; Rudolf Lucas
Journal:  Antioxid Redox Signal       Date:  2020-08-14       Impact factor: 8.401

Review 7.  Staphylococcus aureus Arsenal To Conquer the Lower Respiratory Tract.

Authors:  Mariane Pivard; Karen Moreau; François Vandenesch
Journal:  mSphere       Date:  2021-05-19       Impact factor: 4.389

8.  Staphylococcus aureus Pneumonia: Preceding Influenza Infection Paves the Way for Low-Virulent Strains.

Authors:  Stefanie Deinhardt-Emmer; Karoline Frieda Haupt; Marina Garcia-Moreno; Jennifer Geraci; Christina Forstner; Mathias Pletz; Christina Ehrhardt; Bettina Löffler
Journal:  Toxins (Basel)       Date:  2019-12-17       Impact factor: 4.546

9.  Sequential targeting of interferon pathways for increased host resistance to bacterial superinfection during influenza.

Authors:  Tarani Kanta Barman; Rachael Racine; Jesse L Bonin; Danielle Califano; Sharon L Salmon; Dennis W Metzger
Journal:  PLoS Pathog       Date:  2021-03-09       Impact factor: 6.823

10.  An AI-based auxiliary empirical antibiotic therapy model for children with bacterial pneumonia using low-dose chest CT images.

Authors:  Mudan Zhang; Siwei Yu; Xuntao Yin; Xianchun Zeng; Xinfeng Liu; ZhiYan Shen; Xiaoyong Zhang; Chencui Huang; Rongpin Wang
Journal:  Jpn J Radiol       Date:  2021-06-08       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.